Last updated on November 2017

Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration- CEDAR STUDY


Brief description of study

Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration- CEDAR STUDY

Detailed Study Description

This is a safety and efficacy study of abicipar pegol in patients with neovascular age-related macular degeneration.

Clinical Study Identifier: TX3221

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Susan Sherouse

University of South Florida- USF Eye Institute
Tampa, FL USA
  Connect »